(Q34982069)

5 August 2017

1 reference

title

Intracranial neoplasms in children with neurofibromatosis 1. (English)

1 reference

5 August 2017

Tena Rosser

1

1 reference

PubMed ID

12403562

5 August 2017

Roger J Packer

series ordinal

2

1 reference

5 August 2017

1 August 2002

1 reference

Journal of Child Neurology

5 August 2017

1 reference

5 August 2017

17

1 reference

5 August 2017

8

1 reference

5 August 2017

630-7; discussion 646-51

1 reference

Intracranial gliomas in neurofibromatosis type 1.

5 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700815

Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700815

Spontaneous regression of low-grade astrocytomas in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700815

Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700815

Type 1 neurofibromatosis and the pediatric patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700815

Optic pathway tumors in children: the effect of neurofibromatosis type 1 on clinical manifestations and natural history

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700815

Gliomas of the anterior visual pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700815

Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700815

von Recklinghausen neurofibromatosis. II. Incidence of optic gliomata.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700815

Follow-up of optic pathway gliomas in children with neurofibromatosis type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700815

Precocious puberty in children with neurofibromatosis type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700815

Optic nerve glioma and the management of optic nerve tumours in the young

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700815

Spontaneous regression of optic gliomas: thirteen cases documented by serial neuroimaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700815

Spontaneous partial regression of low-grade glioma in children with neurofibromatosis-1: a real possibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700815

Definitive radiation therapy in the management of symptomatic patients with optic glioma. Survival and long-term effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700815

Long-term outcome of hypothalamic/chiasmatic astrocytomas in children treated with conservative surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700815

An integrated approach to the treatment of chiasmatic-hypothalamic gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700815

Gliomas of the optic nerve or chiasm. Outcome by patients' age, tumor site, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700815

Subsequent quality of life for children irradiated for a brain tumor before age four years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700815

Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700815

Chemotherapy for pediatric brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700815

The management of brainstem gliomas in patients with neurofibromatosis 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700815

Malignancy in neurofibromatosis type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700815

Management of intracranial neoplasms in children with neurofibromatosis type 1 and 2. The Children's Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700815

Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700815

Neurofibromatosis type 1 and childhood cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700815

10.1177/088307380201700815

21 January 2018

Identifiers

DOI

0 references

PubMed ID

12403562

1 reference

PubMed ID

12403562